NewLink Genetics (NLNK) Tops Q4 EPS by 17c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to NewLink Genetics (NLNK) Tops Q4 EPS by 17c

NewLink Genetics Provides Operational Update and Reports Fourth Quarter, Year End 2015 Financial Results

February 29, 2016 8:02 AM EST

NewLink Genetics Outlines 2016 Business Priorities to Support Development of Immuno-Oncology Product Pipeline

Management to Host Conference Call and Webcast Today at 8:30 a.m. ET

AMES, Iowa, Feb. 29, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK), a biopharmaceutical company at the forefront of discovering, developing and commercializing novel immuno-oncology product candidates, including both cellular immunotherapy and checkpoint inhibitor programs, to improve the lives of patients with cancer, today reported business highlights and consolidated financial results for the fourth quarter and year ended 2015.  NewLink Genetics also outlined key... More